CCL5 production in lung cancer cells leads to an altered immune microenvironment and promotes tumor development

Current immunotherapies for lung cancer are only effective in a subset of patients. Identifying tumor-derived factors that facilitate immunosuppression offers the opportunity to develop novel strategies to supplement and improve current therapeutics. We sought to determine whether expression of driv...

Descripción completa

Detalles Bibliográficos
Autores principales: Melese, Etienne S., Franks, Elizabeth, Cederberg, Rachel A., Harbourne, Bryant T., Shi, Rocky, Wadsworth, Brennan J., Collier, Jenna L., Halvorsen, Elizabeth C., Johnson, Fraser, Luu, Jennifer, Oh, Min Hee, Lam, Vivian, Krystal, Gerald, Hoover, Shelley B., Raffeld, Mark, Simpson, R. Mark, Unni, Arun M., Lam, Wan L., Lam, Stephen, Abraham, Ninan, Bennewith, Kevin L., Lockwood, William W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038050/
https://www.ncbi.nlm.nih.gov/pubmed/35481284
http://dx.doi.org/10.1080/2162402X.2021.2010905

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038050/
https://www.ncbi.nlm.nih.gov/pubmed/35481284
http://dx.doi.org/10.1080/2162402X.2021.2010905

Ejemplares similares